Table 1. Phenotype of IL4-DC and IL15-DC Stimulated with TLR Agonists.

		media		Pam3CSK4		poly (I:C)		LPS
		IL4-DC	IL15-DC	IL4-DC	IL15-DC	IL4-DC	IL15-DC	IL4-DC	IL15-DC
IL-15	%	0–2	0–6	0–1	26–57	0–2	63–75	0–3	68–76
	MFI	2–4	5–7	3–5	8–14	4–5	8–14	4–5	8–18
CD83	%	2–12	0–4	47–65	0–23	72–94	0–31	88–93	28–46
	MFI	18–26	16–54	71–116	24–42	73–108	15–51	81–138	12–53
HLA-DQ	%	92–94	96–98	89–95	96–97	96–97	90–97	95–97	94–96
	MFI	27–56	52–96	64–158	74–124	104–169	75–138	99–163	72–137
HLA-DR	%	93–95	97–98	96–99	96–99	98–99	92–98	97–99	96–98
	MFI	162–246	284–468	368–528	559–792	489–517	631–976	513–550	651–1087
HLA-E	%	0–1	80–81	0	43–70	0–1	48–70	1–28	44–64
	MFI	6–7	27–40	4–6	22–37	6–7	27–37	6–23	24–35

MFI, Mean fluorescence intensity.